MRI guidance of Doxorubicin release from liposomes stimulated by pulsed low intensity non-focused Ultrasound in an experimental tumor model Silvia Rizzitelli, Pierangela Giustetto, Juan Carlos Cutrin, Marta Ruzza, Cinzia Boffa, Daniela Delli Castelli, Valeria Menchise, Filippo Molinari, Silvio Aime, and Enzo Terreno Department of Molecular Biotechnology and Health Sciences, Molecular Imaging Ce...

Institute of Plant and Microbial Biology, Academia Sinica, Taipei 11529, Taiwan (M.N.K., W.-N.J., P.E.V.); Molecular and Biological Agricultural Sciences Program, Taiwan International Graduate Program, Academia Sinica, Taipei 11529, Taiwan and Graduate Institute of Biotechnology, National Chung-Hsing University, Taichung 402, Taiwan (M.N.K., P.E.V.); and Biotechnology Center, National Chung-Hsi...

Abstract
 The article presents the history of establishment and development Institute Molecular Biology at Jagiellonian University, describes reasons for transformation into Faculty Biochemistry, Biophysics Biotechnology, provides information on current scientific teaching potential prospects further development.

This review gives an insight into the recent advancements in biotechnology with respect to its application in the environment. Particular emphasis is on food production, pollution control and bioenergy production. Environmental biotechnology combines molecular biology and cell manipulation in order to produce valuable products with a lot of new, effective and acceptable properties. Global food ...

Pyoverdine Receptor: a Case of Positive Darwinian Selection in Pseudomonas aeruginosa Burkhard Tümmler* and Pierre Cornelis Klinische Forschergruppe, OE6711, Medizinische Hochschule Hannover, D-30625 Hannover, Germany, and Flanders Interuniversity Institute of Biotechnology (VIB6), Laboratory of Microbial Interactions, Department of Molecular and Cellular Interactions, Flanders Interuniversity ...

Biomolecular Computation (BMC) is computation done at the molecular scale, using biotechnology techniques. This paper discusses the underlying biotechnology that BMC may utilize, and surveys a number of distinct paradigms for doing BMC. We also identify a number of key future experimental milestones for the eld of BMC.

Moitza Principe1,2, Paola Cappello1,2,3 and Francesco Novelli1,2,3,4* 1Center for Experimental Research and Medical Studies (CeRMS), Azienda Universitaria Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy 2Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy 3Molecular Biotechnology Center, University of Turin, Italy 4Imunogenetics and Trans...